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Appendix A

the next 10 years or the diagnosis of an epilepsy
syndrome is clear.

Epilepsy in Pakistan: Classification and Diagnosis
Guidelines for Clinicians:

The Seizure:
A seizure is defined as a clinical manifestation of
abnormal discharges of a group of cortical neurons. For
the purpose of these guidelines seizures are divided into
two main categories

QUESTIONS ADDRESSED
Q1-Definition of Epilepsy: Adapted from New definition of
ILAE review statement 2104
Q2-Q5-Classification of seizures, Epilepsy and epilepsy
syndromes and etiologic basis
Q5-Q10-Diagnosis (history, physical exam, relevant lab
tests, EEG, Neuroimaging)

Focal/Partial and Generalized.
Focal seizures or partial arise from a focal point in the
brain that can be identified by history. An aura is always a
sign of a focal seizure. Focal seizures can be simple partial
or complex partial. Generalized seizures do not have an
identifiable focal point and involve entire brain at the
onset.

Definition of Epilepsy:
In 2013 an international taskforce of the ILAE shaped out
a communal definition of Epilepsy.(2) This definition is useful
for all or most practical purposes, thus more helpful in
management. Epilepsy was defined as recurrent
unprovoked seizures i.e 2 or more at least 24 hours apart.
The revised practical definition implies that Epilepsy can be
considered even after a single seizure in individuals who
have other factors predictive of a second unprovoked
seizure, a risk set at 60%. The factors include the diagnosis
of an epilepsy syndrome, structural lesions like stroke, CNS
infections, intraparenchymal contusions after trauma, as
well as reflex seizures such as photosensitive seizures. (3)

Simple Partial Seizures
• Locus
– one site or lobe
• Manifestations
– Duration: ~30secs
– Involuntary muscle jerks, sensory (tastes or
smells), psychic or emotional (fear)
– Foul smell, metallic taste, light-headedness,
bright light, rising sensation in stomach.
• Consciousness
– Retained

Table 1 (2)
A person is considered to have epilepsy if they meet any
of the following conditions:
At least two unprovoked (or reflex) seizures occurring
greater than 24 hours apart.
One unprovoked (or reflex) seizure and a probability of
further seizures similar to the general recurrence risk (at
least 60%) after two unprovoked seizures, occurring over
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Complex Partial Seizures
• Locus
– One or multiple sites, TLE
• Manifestations
– Duration: 1-3 min
– Automatisms (picking at clothes, lip smacking,
wandering, repeating words)
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•

Table 3.

– May begin with SPS (aura)
Consciousness
– loses consciousness

Classification of Neonatal
Seizures

Generalized Seizures
• Primary generalized
– Locus: both hemispheres affected from outset
– Manifestation:
•
Duration ~2mins
•
Muscles rigid(tonic)-person falls down,
rhythmic muscle contractions (Clonic),
shallow breathing, incontinence, post
ictal drowsiness, and confusion
•
Usually no aura or warning
•
Consciousness is lost
• Secondarily generalized
– Preceded by SPS or CPS

ELECTROENCEPHALOGRAPHIC SEIZURE

CLINICAL SEIZURE

COMMON

UNCOMMON

Subtle
+*
Clonic
Focal
+
Multifocal
+
Tonic
Focal
+
Generalized
+
Myoclonic
Focal, multifocal
+
Generalized
+
--------------------------------------------------------------------------------------------------------------*Only specific varieties of subtle seizures are commonly associate with simultaneous
Electroencephalographic seizure activity.
Volpe JJ.Neonatal Seizures:Neurology of the Newborn.4th ed.

Table 4.
Seizure Types :(20)
• Simple Partial and Aura
– Consciousness retained
• Complesx partial
– Consciousness impaired
• Secondarily generalized
– Seizures that begin with a focal onset like aura, or
evolve from partial onset and progress to generalized seizure

•
•

Neonatal Seizures
• Odd presentation
• Not follow usual classification of Partial and
generalized seizures
• Focality very difficult to assess

Simple partial and complex partial with or without
generalization are considered focal when groped into
syndromes
•

Generalized
– Tonic
– Clonic
– Tonic clonic
– Atonic
– Absence
•
Typical
•
Atypical
– Absence with special features – Myoclonic
absence ; Eyelid myoclonia
– Myoclonic
– Myoclonic aestatic
• Unknown Epileptic spasms
• Non epileptic Seizures
(Seizures that cant be clearly diagnosed into one of the
preceding categories should be considered unclassified
until further information allows for their accurate diagnosis)

Clinical Seizure
• Subtle
• Tonic
• Clonic
• Myoclonic
Table 2.
Subtle Sz
• More in preterm
than in term
• Eye deviation
(term)
• Blinking, fixed
stare (preterm)
• Repetitive mouth
and tongue
movements
• Apnea
• Pedaling and
tonic posturing of
limbs

Tonic Sz
• Primarily in
Preterm
• May be focal or
generalized
• Sustained
extension of the
upper and lower
limbs (mimics
decerebrate
posturing)
• Sustained flexion
of upper with
extension of lower
limbs (mimics
decorticate
posturing)
• Signals severe
ICH in preterm
infants

Clonic Sz
• Primarily in term
• Focal or
multifocal
• Clonic limb
movements
(synchronous or
asynchronous,
localized or often
with no anatomic
order of
progression)
• Consciousness
may be preserved
• Signals focal
cerebral injury

Myoclonic Sz
• Rare
• Focal,
Nnmultifocal or
generalized
• Lightning-like
jerks of
extremities
(upper > lower)
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EPILEPSY SYNDROMES
• Often provides information on how long the seizures
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(ADNFLE)
Late onset childhood occipital epilepsy (Gastaut type)
Epilepsy with myoclonic absences
Lennox-Gastaut syndrome
Epileptic encephalopathy with continuous spike-and-wave
during sleep (CSWS)
Landau-Kleffner syndrome (LKS)
Childhood absence epilepsy (CAE)

persist and which medications can be useful and which to
avoid.
• Defined by a cluster of characterstics
– seizure type
– EEG findings
– neurologic status
– age at onset
– family history
– prognosis

Adolescence – Adult
Juvenile absence epilepsy (JAE)
Juvenile myoclonic epilepsy (JME)
Epilepsy with generalized tonic–clonic seizures alone
Progressive myoclonus epilepsies (PME)
Autosomal dominant epilepsy with auditory features
(ADEAF)
Other familial temporal lobe epilepsies
Less specific age relationship
Familial focal epilepsy with variable foci (childhood to
adult)
Reflex epilepsies
Distinctive constellations (lesion related symptomatic)
Mesial temporal lobe epilepsy with hippocampal
Sclerosis (MTLE with HS)
Frontal lobe Epilepsy (FLE)
Occipital Lobe Epilepsy (OLE)
Rasmussen syndrome
Gelastic seizures with hypothalamic hamartoma
Hemiconvulsion–hemiplegia–epilepsy
Epilepsies that do not fit into any of these diagnostic
categories can be distinguished first on the basis of the
presence or absence of a known structural or metabolic
condition (presumed cause) and then on the basis of the
primary mode of seizure onset (generalized vs. focal)
Epilepsies attributed to and organized by structuralmetabolic causes
Malformations of cortical development (hemimegalencephaly,
heterotopias, etc.)
Neurocutaneous syndromes (tuberous sclerosis complex,
Sturge-Weber, etc.)
Tumor
Infection
Trauma
Angioma
Perinatal insults
Stroke
Etc.
Epilepsies of unknown cause
Conditions with epileptic seizures that are traditionally not
diagnosed as a form of epilepsy per se
Benign neonatal seizures (BNS)
Febrile seizures (FS) (22)
Childhood
Febrile seizures plus (FS+) (can start in infancy)
Panayiotopoulos syndrome

For the sake of brevity and practical applicability of these
guidelines the syndromes are simplified in few main
categories
Overall three categories in adults three more in children
1. Idiopatic Generalized Epilepsy (IGE) (Juvenile myoclonic
epilepsy, absance, GTC, tonic, atonic)
2. Symptomatic localization related epilepsy(SLRE)
– Temporal lobe epilepsy
– Frontal lobe epilepsy
– Occipital lobe epilepsies
3. Symptomatic Generalized Epilepsy eg Lennox- Gastaut
syndrome
4. Other Epilepsies like Febrile seizures
5. West syndrome (Infantile spasms)
6. Benign rolandic epilepsy in children
Others like Reflex epilepsies and metabolic syndromes
A detailed list of Epilepsy syndromes is outlined in table 5.
Table 5
EPILEPSY SYNDROMES: (21-22)
Epilepsy syndromes arranged by age at onset
•

•
•

Neonatal period
– Benign familial neonatal epilepsy (BFNE)
– Early myoclonic encephalopathy (EME)
– Ohtahara syndrome
Infancy
– Epilepsy of infancy with migrating focal seizures
– West syndrome
Myoclonic Epilepsy in infancy (MEI)

Benign infantile epilepsy
Benign familial infantile epilepsy
Dravet syndrome
Myoclonic encephalopathy in nonprogressive disorders
Panayiotopoulos syndrome
Epilepsy with myoclonic atonic (previously astatic) seizures
Benign epilepsy with centrotemporal spikes (BECTS)
Autosomal-dominant nocturnal frontal lobe epilepsy
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–
hypo/hyperglycemia
–
migraine
–
Vertigo
– intra ventricular colloid cyst,
– cataplexy,
– Acute
symptomatic
seizure
secondary
to
hypoglycemia, alcohol intake, alchohol withdrawal,
hyponatremia, eclampsia etc.

Epilepsy with myoclonic atonic (previously astatic)
seizures
DIAGNOSIS
Making the correct diagnosis is the key to all
management. In PWE there are major health, educational
and psycho-social implications. It is most important that
the physician is sensitive to PWEs and their families when
communicating the diagnosis of epilepsy. Epilepsy
remains a clinical diagnosis and it can be difficult.
Misdiagnosis is frequent about 25% of cases in developed
countries, much higher particularly when made by non
neurologists. This itself can cause social and financial
losses due to the wrong label, not to mention the side
effects of unnecessary treatment as well. Conversely
Individuals may die because diagnosis was not made. The
diagnosis of Epilepsy remains a clinical diagnosis with all
tests providing supplementary data.

Differentiating seizures from syncope/LOC
Questions to ask and if “yes”, support a diagnosis of
epileptic seizure:
• At times do you wake up with a cut tongue after your
spells?
• At times do you have a sense of déjà vu or jamais vu
before your spells?
• At times is emotional stress associated with losing
consciousness?
• Has anyone noticed your head turning during a spell?
• Has anyone ever noted that you are unresponsive, have
unusual posturing or have jerking
limbs during your spells or have no memory of your spells
afterwards?
• Has anyone noticed that you are confused after a
spell?
• Have you had any episodes while lying down or during
sleep?

History
• A detailed history should be taken from the child,
young person or adult
• An eyewitness to the attack, where possible, to
determine whether or not an epileptic
seizure is lllikely to have occurred.
• The clinical decision as to whether an epileptic
seizure has occurred should then be based on the
combination of the description and the different
symptoms.
• Diagnosis should not be based on the presence or
absence of a single feature.

Questions if “yes”, support a diagnosis of syncope:
• Have you ever had light-headed spells?
• Are all your attacks during the erect position?
• At times do you sweat before your spells?

Physical Exam
PWE presenting with a seizure, a physical examination
should be carried out. Vitals, inspection of skin, in children
a general physical especially abdominal to r/o hepatosplenomegaly.
Include their cardiac, neurological and mental status and
in case of children a developmental assessment where
appropriate. [18]
Follow-up should always be arranged
Where non-epileptic attack disorder is suspected, first rule
out organic cause then make suitable referral to
psychological or psychiatric services for further
investigation and treatment.

Differentiating PNES with NES
Questions if “yes” support a diagnosis of PNES:
• Are all events during waking?
• Are you aware of the surroundings while you are
unable to respond?
• Is there pelvic thrusting and bicycling that lasts for
more usually longer than a couple of minutes.
• Do they always occur in the presence of someone or
during an argument?
• Do they last for hours ?
• Do they wax and wane over the span of hours with no
stereotype?
Questions if “yes” support a diagnosis of ES:
• Are the episodes stereotyped and brief?
• Do they occur during sleep?
• Are they associated with incontinence?
• Is there tongue bite on lateral edges of the tongue?

Epilepsy: Differential Diagnosis
• Many other conditions may be confused with
epilepsy:
–
syncope - reflex, cardiac, postural
–
Psychogenic non epileptic seizures PNES
–
TIA
–
panic attacks
–
sleep disorders
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In Children
Breath holding spells, febrile fits, syncope, parasomnias,
behavioral issues should be differentiated.
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Role of Home video”s and written discrptions
Prospective recording of events, including video recording
and written descriptions, can be very
helpful in reaching a diagnosis.

abnormalities that cause certain epilepsies.
It is recommended in patients with focal onset seizures or
multifocal seizures or when there is an acute change in
seizure semiology and frequency in a compliant previously
controlled PWE.

Investigations
A range of investigations, chiefly EEG and brain imaging,
are available to assist the clinician in Classifying seizures
and epilepsy syndromes of individuals suspected as
having epilepsy.
Q. The role of EEG in making a diagnosis of epilepsy :
1. An EEG should be performed to support a diagnosis
of epilepsy in PWE in whom the
clinical history suggests that the seizure is likely to be
epileptic in origin.
2. The normalEEG should not be used to exclude a
diagnosis of epilepsy in PWE in whom
the clinical presentation supports a diagnosis of a
non-epileptic event.
3. The EEG should not be used in isolation to make a
diagnosis of epilepsy.
6. The EEG should be reported by a qualified
neurophysiologist to minimize over/under reporting.
These not being available arrangements for workshops
and doubtful tracings to be sent to qualified
neurophysiologists be made.
7. The finding of interictal epileptiform activity on EEG
can be used to help confirm the
Clinical diagnosis of an epileptic seizure. A negative EEG
cannot be used to rule out the
clinical diagnosis of an epileptic seizure.
8. When a standard EEG has not contributed to
diagnosis or classification, a sleep EEG should be
performed.A sleep EEG is best achieved through sleep
deprivation or the use of
Melatonin
9. A routine EEG should include activation procedures
like photic stimulation and hyperventilation if not
contraindicated due to state and condition of the patient.
10. Chloral hydrate, clonazepam (in children) and
midazolam, diazepam or other benzodiazepines should
not be used to sedate the patient prior to EEG.
11. When Temporal lobe Epilepsy is in the differential
extra anterior tempotal leads should be applied T1 and T2
preferably
12. When occipital lobe involvement is in the differential
or occipital discharges are noted a posterior halo or
headband montage should be used.
13. Longterm video EEG should be used in PWE who
present with diagnostic difficulties after clinical
assessment and standard EEG is not supportive or
questionable as well as PNES suspected cases.

1. MRI should be the imaging investigation of choice in
children, young people and adults with epilepsy. (specified
seizure protochol see appendix)
MRI is particularly important in those:
• who develop epilepsy before the age of 2 years or in
adulthood
• who have any suggestion of a focal onset on history,
examination or EEG (unless clear
evidence of benign focal epilepsy)
• in whom seizures continue in spite of first-line
medication.
2. Neuroimaging should not be routinely requested
when a diagnosis of idiopathic
generalized epilepsy has been made.
3. CT should be used to identify underlying gross
pathology if MRI is not available or is contraindicated, and
for children and young people in whom a general
anaesthetic or sedation would be required for MRI but not
CT. The CT should be at least 64 slice scanner and thin
cuts with axial and coronal views.
4. In an acute situation, CT may be used to determine
whether a seizure has been caused by an acute
neurological lesion or illness.
The Seizure Protocol MRI : Special Thanks to
Dr. Zafar Sajjad, Professor, Department Of Radiology,
Aga Khan University, Karachi.
Recommendations
• MRI request should say Seizure protocol
• Though a screening protocol has been put in the end
it is important to reiterate that screening MRIs for strokes
and tumors on low field strength machines (becoming a
norm through Pakistan) is a false economy for Epilepsy.
• All MRI centers should have the protocol and guide
the patient if they do not have the specifics.
Protocol Considerations
1. Axial T1 and T2 images standard SE/TSE 5mm should
be done in all cases.
2. Fluid inversion (FLAIR) sequences in Coronal Plane in
all PWE
3. Gadolinium contrast enhancement increases the cost
further and is not necessary in routine cases but helpful
in selected cases In patients where sedation or GA is
required to enable the test the cost of not doing the
contrast scan may be higher if the entire procedure is to
be repeated.
Patients should have at least 1 contrast enhanced scan in

The role of neuroimaging in the diagnosis of epilepsy
Neuroimaging should be used to identify structural
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should be checked especially when on AED’s.

the course of their disease.
4. Coronal Flair and T2 images in all seizure protocols
irrespective of whether contrast is given or not. If contrast
is given post contrast coronal should also be taken.
5. If temporal lobe epilepsy is in the differential : Coronal
FLAIR and High Resolution, thin section T2 sequences
perpendicular to the long axis of the hippocampus, with
and without contrast.
6. If cortical dysplasia is suspected: Sagittal T1 along
with Axial T1, T2 FSE/TSE , Axial FLAIR Axial DWI / ADC .
Coronal T2, and 3D Volume GRE – T1, thin-section,
whole brain but If there is a known EEG focus then do the
coronal thin T2 and FLAIR (from the MTS protocol) in the
suspicious EEG location. If any abnormality noticed, then
give contrast. NOTE: This will apply only to the paediatric/
adolescent population. In this a T1 GRE volume and a T1
IR sequence would be sufficient. DWI is now standard of
care on all brain MRIs and should be acquired irrespective
of indication.
7. T1 GRE volumes and T1 IR axial slices in all patients
below the age of 18 years.

Cardiovascular tests as an aid to diagnosis
1. A 12-lead ECG should be performed in adults over age
30 with suspected epilepsy.
2. In children and young people, a 12-lead ECG should
be considered in cases of diagnostic
uncertainty.
3. In cases of atypical attacks and strong possibility 0f
syncope or any arrhythmia on EKG, a referral to a
cardiologist should be considered.
The role of neuropsychological assessment in the
diagnosis and management of epilepsy?
Neuropsychological deficits are commonly associated with
epilepsy and its treatment. Awarenes of these problems
may facilitate education, social integration and
employment
1. Neuropsychological
assessment
should
be
considered in children, young people and adultin whom it
is important to evaluate learning disabilities and cognitive
dysfunction,
particularly in regard to language and memory.
2. when a child, young person or adult with epilepsy is
having educational or occupational
difficulties
3. when an MRI has identified abnormalities in
cognitively important brain regions
4. when a child, young person or adult complains of
memory or other cognitive deficits and/or cognitive
decline.

Recommendation for a Standardized Seizure
protocol MRI:
Should only be carried out on a high field strength (1.5T
or above) magnet
Axial TSE T2 5mm
Axial SE T1 5 mm
Coronal FLAIR 5mm
Coronal High Resolution T2 perpendicular to the
hippocampus
Axial DWI min b=1000
Post contrast Axial T1 and FLAIR coronal
For the paediatric age group add:
T1 GRE volume. Primary acquisition in the coronal plain.
T1 IR Axial or coronal
For focal seizures or secondary generalization add
SWI Axial
eople (9)
Show details

Conclusion
The primary scope of these guidelines is to provide a
concise practical plan which will help identify the seizure,
and classify it in the simplest possible form. These
guidelines hope to provide the physicians treating epilepsy
patients with a step wise approach to the diagnosis
patient with epilepsy. Though some of these diagnostic
tests are expensive making the correct diagnosis at an
initial stage of the disease can same much in long term
cost of morbidity and polypharmacy.
A health care structure needs to be created on the
governmental level to provide subsidized AEDs and
diagnostic facilities.
These guidelines will be revisited and modified on
applicability every four years. People with epilepsy remain
at the centre of this guideline, and the need for services
to consider the needs of each individual and their care
givers have been focused.

Laboratory tests
1. Measurement of serum prolactin is not
recommended for the diagnosis of epilepsy.
2. In adults, appropriate blood tests (for example,
plasma electrolytes, glucose, calcium) to
identify potential causes and/or to identify any significant
co-morbidity should be considered.
3. In children and young people, other investigations,
including blood and urine biochem
should be undertaken at the discretion of the specialist to
exclude other diagnoses, and to
determine an underlying cause of the epilepsy.
4. B12, vitamin D and serum iron, Mg, Ca, LFTs and
serum creatine kinase, complete blood count, creatinine
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EPILEPSY IN CHILDREN AND NEONATES
Diagnosis:
Making the correct diagnosis is extremely important in
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children due to long term implications like educational,
psychosocial, intelligence quotient, development, self
esteem and the psychological impact on their parents.
Misdiagnosis is more common in peads than in adults,
particularly when diagnosis is made by non specialists.
Recognizing and classifying seizures is different in
neonates , infants and children as does the etiology and
management.
Classification:
See Appendix A
Treatment:
The basic principles of AED treatment in children with
epilepsy (CWE) remain the same as in adults. CWE should
be encouraged to participate in normal activities with their
peers , supervised where needed depending on the type
of activity and seizure history. Parents of CWE should be
advised not to be over protective.
NEONATAL SEIZURES
Diagnosis of neonatal seizures is essentially clinical and
must be based on observation of repeated or rhithmic
activity which is (subtle) for example orofacial twitching,
(clonic) limb movements, jerking not stopped when held,
autonomic disturbances, stiffening (tonic) or sustained
posturing of limbs. Home video of events is helpful in
diagnosis and further management of such neonates
needs to be done under specialized care.

• Neonatal screening TSH,
• lactic acid, if acidosis biotin should be given and
acidosis corrected.
•
serum AA and urine organic acids if inborn errors
suspected e.g. sibling history or consanguineous marriage.
• Stabilize vital signs and treat underlying hypotension
• Correct transient metabolic disturbances
• Phenobarbital is first line agent
• Lorazepam and Phenytoin second line
• Valproate and Levitiracetam if myoclonic fits.
• See table for oral AEDs that can be used
• Refer to Pediatric Neurologist ASAP

Table 1: Causes of Neonatal seizures
HIE (32%)
Intracranial hemorrhage (17%)
CNS infection (14%)
Infarction (7%)
Metabolic disorders (6%)
Inborn errors (3%)
Unknown (10%)
Drug withdrawal (1%)

Table 3. Oral AEDs that can be used in Neonatal seizures
Primidone: 15 to 25 mg/kg per day in 3 doses
Clonazepam: 0.1 mg/kg in 2 to 3 doses
Carbamazepine: 10 mg/kg, then 15 to 20 mg/kg per day in 2 doses

Ideal Metabolic Evaluation should include:
•
Blood: glucose, lytes, BUN, creatinine, lactate,
pyruvate, ammonia, biotinidase, quantitative amino acids,
very long chain fatty acids
• Urine: quantitative amino acids
• CSF: cell count, glucose, protein, pyruvate, lactate,
quantitative amino acids, HSV PCR
Unfortunately these are very costly and some need to be
sent abroad increasing cost.

Valproic acid: 10 to 25 mg/kg, then 20 mg/kg per day in 3 doses
(avoid iv in neonates but can be given with L carnitine if refractory
sz)
Vigabatrin: 50 mg/kg per day in 2 doses, up to 200 mg/kg per day
(caution visual field defects) Lamotrigine: 12.5 mg in 2 doses (care
needed to tirate caution SJS, TE) Zonisamide: 2.5 mg/kg per day
Levetiracetam: 10 mg/kg per day in 2 doses. I.V available can be
used as add-on esp where myoclonus is prominent) 2012
Folinic acid: 2.5 mg BID, up to 4 mg/kg per day,
Folinic acid, biotin and pyridoxine trial in refractory cases
prednisolone 1mg/kg if all else fails

General Recommendations
• All neonates with seizures should be given pyridoxine
50-100mg
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unless it is unsuitable. Be aware of teratogenic risks of
sodium valproate. NOTE: Ethosuximide is not available in
Pakistan.
2. Lamotrigine if ethosuximide and sodium valproate are
unsuitable, ineffective or not tolerated.
3. If two firstline AEDs are ineffective in patients with
absence seizures, consider a combination of two of these
three AEDs as adjunctive treatment: ethosuximide,
lamotrigineor sodium valproate. Be aware of teratogenic
risks of sodium valproate
4. If adjunctive treatment is ineffective or not tolerated,
discuss with, or refer to epilepsy specialist and consider
clobazam, clonazepam, levetiracetam, topiramate,or
zonisamide (not available in Pakistan)
5. Do not offer carbamazepine, gabapentin, oxcarbazepine,
phenytoin, pregabalin, tiagabine or vigabatrin.
6. Avoid VPA with clonazepam in childhood absences it
can induce absence status

Acute Therapy of Neonatal seizures :
If with hypoglycemia- Glucose 10%: 2ml/k IV
If no hypoglycemia- Phenobarbital:20mg/k IV
loading dose
If necessary : additional phenobarbital:
5 mg/kg IV to a max of 20 mg/kg
(omit if respiratory compromise)
Phenytoin: 20 mg/kg, IV (1 mg/kg/min)
Lorazepam:0.05-0.10 mg/kg, IV
All neonates with intractable seizures should be given
50-100mg iv pyridoxine.
FEBRILE SEIZURES or FITS (FF)
1. Fits that occur in otherwise normal infants from age 6
months to 6years on during high fever greater than 101oF
or 38oC. (fever not caused by meningeal or cerebral
infection)
2. Single FF occurs in 3-5% of children. Recurrent FF
occurs in one third of children with FF. Recurrance is
higher if first FF within first year of life.
3. FF may be simple or complex and this helps
prognosticate the FF. Simple is brief, generalized <1min.
Complex FF comprise only 15% of FF, usually partial onset,
longer >15 minutes or multiple fits in the same illness.
These are more likely to develop epilepsy in the future.
4. LP (lumbar puncture) should be done in children
suspected of CNS infection
5. Recurrent simple FF do not warrant investigation and
need parental counseling
6. EEG is not required in Simple FF. it should be done in
complex FF, febrile status epilepticus.
7. FF is never focal
8. Neuroimaging has no role in simple FF
9. FF counseling should include lowering body
temperature, acutely acting antiepileptic drugs like
diazepam orClobazam 0.75mg/kg in two divided doses,
or phenobarbitone prophylactically during fever only.
10. Continued prophylaxix with AEDs is not recommended
in FF.
11. Parents need to be taught the use of rectal diazepma
0.5mg/kg and/or buccal midazolam (0.2-0.3mg/kg) for
acute termination of seizure if lasts longer than 2 minutes.
12. Parents should be cautious not to let fever rise in
such children

Childhood Absence Epilepsy :
Recommendations for Pakistan
2nd Choice

VPA

LTG

3rd Choice

Clobazam,
Clonazepam
LEV
TPM

Pharmacological management of myoclonic seizures
1. Offer VPA as first-line treatment to children, with newly
diagnosed myoclonic seizures,
unless it is unsuitable.
2. Offer LEV or TPM if VPA is not suitable or patient not
responding
(Be aware that TPM has a less favourable sideeffect
profile than LEV and VPA)
3. Offer LEV, VPA or TPM as adjunctive treatment to
children, with myoclonic seizures if firstline treatments are
ineffective or not tolerated. Be aware of teratogenic risk of
VPA
4. If adjunctive treatment is ineffective or not tolerated,
discuss with, or refer to, epilepsy specialist and consider
clobazam,clonazepam, piracetam or zonisamide or
steroids.
5. Do not offer carbamazepine, gabapentin, oxcarbazepine,
phenytoin, pregabalin, tiagabine or vigabatrin.

CHILDHOOD Specific EPILEPSY SYNDROMES:
(pharmachologic management)
Pharmacological management of ABSENCE
SEIZURES

Pharmacological management of INFANTILE SPASMS
1. Discuss with, or refer to, a tertiary paediatric epilepsy
specialist when an infant presents with infantile spasms.
These children will need polytherapy.
2. Offer a steroid (prednisolone or tetracosactide or ACTH)

1. Ethosuximide or sodium valproate as firstline treatment
to children, patients with
absence seizures. If there is a high risk of GTC seizures,
offer sodium valproate first,
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or vigabatrin with VPA as first-line treatment to infants with
infantile spasms that are not due to tuberous sclerosis.
Carefully consider the risk-benefit when using vigabatrin
or steroids.
3. Offer vigabatrin with VPA as first-line treatment to
infants with infantile spasms due to tuberous sclerosis. If
vigabatrin is ineffective, offer a steroid (prednisolone or
tetracosactide Carefully consider the risk-benefit when
using vigabatrin or steroids.

4. Consider adjunctive treatment if a second well-tolerated
AED is ineffective.
5. Offer clobazam, gabapentin, LTG, LEV, OXC, VPA, TPM,
LCM if first-line treatments fails
Refractory childhood epilepsy syndromes adjuvant
AEDs
Other AEDs that may be considered by the tertiary
epilepsy specialist are eslicarbazepine
acetate, pregabalin, tiagabine, vigabatrin, LCM, and
zonisamide,PB, PHT, TPM,
Carefully consider the risk–benefit ratio when using
vigabatrin due to irreversible visual field constriction in
upto 30%
Ketogenic diet, medical marijuana, methylprednisone,
clobazam, nitrazepam, clonazepam, lorazepam are also
recommended in refractory cases.

Pharmacological management of Dravet syndrome
1. Discuss with, or refer to, a tertiary paediatric epilepsy
specialist when a child presents with suspected Dravet
syndrome.
2. Consider VPA or TPM as first-line treatment in children
with Dravet syndrome.
3.If first-line treatments in patients with Dravets syndrome
are ineffective or not tolerated try clobazam or stiripentol
(* not available in Pakistan) as adjunctive treatment.
4. Do not offer CBZ, gabapentin, LTG, OXC, PHT,
pregabalin, tiagabine or vigabatrin.

Note
• In children, the diagnosis and management of
epilepsy within the first few years of life may be extremely
challenging. For this reason, children with suspected
epilepsy should be referred to tertiary services early,
because of the profound developmental, behavioural and
psychological effects that may be associated with
continuing seizures.
• Behavioural or developmental regression or inability
to identify the epilepsy syndrome requires immediate
referral to tertiary services.
• Children, young people and adults with specific
syndromes such as Sturge–Weber syndrome, the
hemispheric syndromes, Rasmussen’s encephalitis and
hypothalamic hamartoma should be referred to a tertiary
epilepsy service.
• All PWE and learning disabilities should have a risk
assessment including:
• bathing and showering
• preparing food
• using electrical equipment
• managing prolonged or serial seizures
• the impact of epilepsy in social settings
• SUDEP

Pharmacological management of LENNOX-GASTAUT
SYNDROME
1. Discuss with, or refer to, a tertiary paediatric/ epilepsy
specialist when a child presents
with suspected Lennox–Gastaut syndrome. Most require
poly-therapy
2. Offer VPA as first-line treatment to children with
Lennox–Gastaut syndrome.
3. Offer LTG, TPM as adjunctive treatment if first-line
treatment with VPA is ineffective or not
tolerated.
4. Other AEDs that may be considered by the tertiary
epilepsy specialist are rufinamide and topiramate and
polypharmacy with benzodiazepines, trial of steroids may
also be considered.
5. Do not offer CBZ, gabapentin, OXC, pregabalin,
tiagabine or vigabatrin.
Pharmacological management of BENIGN EPILEPSY
WITH CENTROTEMPORAL
SPIKES,(BECTS)
1. Discuss with the child, and their family whether AED
treatment for benign epilepsy with
Centro-temporal spikes,
2. Offer LTG or CBZ* as first-line treatment.
3. Offer LEV, OXC*, or VPA(avoid in older girls) as 2nd line
if above fail
(*Be aware that carbamazepine and oxcarbazepine may
exacerbate or unmask continuous spike and wave during
slow sleep, which may occur in some children with benign
epilepsy with centrotemporal spikes. Be aware of
teratogenic risks of VPA and rash with LTG.)
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Annexure: RCT review and our modifications)
Partial Seizures: Children
Recommendations
Level A: OXC
Level B: None (RTC) LTG (NICE)
Level C: CBZ, PB, PHT,TPM, VPA, VGB
Level D: LTG, ZNS, CLB, CZP
Level E: Others
Level F: None
Recomendations: PB*, VPA, CBZ, OXC, LTG,
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Generalized Tonic Clonic Seizures: Children
Recommendations
Level A: None
Level B: None
Level C: CBZ*,PB, PHT*,TPM,VPA
Level D: OXC* LEV, LTG, (considered first line NICE)
Level E: Others
Level F: None
*may aggravate tonic clonic seizures and more commonly
other generalized seizure types, should be used with
caution

accurate information and counselling about contraception,
conception, pregnancy, caring for children and
breastfeeding, and menopause.
• All healthcare professionals who treat, care for, or
support women and girls with epilepsy should be familiar
with relevant information and the availability of counseling
the risk of AEDs causing malformations and possible
neurodevelopmental impairments in an unborn child.
• Assess the risks and benefits of treatment with
individual drugs. There are limited data on risks to the
unborn child associated with newer drugs. Specifically
discuss the risk of continued use of sodium valproate to
the unbornchild, being aware that higher doses of sodium
valproate (more than 800 mg/day) and polytherapy,
particularly with sodium valproate, are associated with
greater risk. (see table drugs and teratogenicity)

Women of childbearing age with epilepsy
Introduction
Most women with epilepsy who are receiving optimal
treatment for their epilepsy, and who are well-informed,
supported and fully counselled have uncomplicated
pregnancies, normal deliveries, and healthy children.
However in Pakistan no such proper program or
counseling or management plan is available. Thus number
of complications and perinatal problems are high in WWE
(women with epilepsy). A number of issues need to be
considered

CONTRACEPTION
1. CBZ, PHT, OXC, TPM and barbiturates reduce the
effectiveness of oral contraceptives
necessitating the use of alternative methods, or special
highdose regimens of oral contraceptives. Even with this
precaution, the effectiveness of the oral contraceptive is
reduced. (Ia NICE)
2. Hormone-releasing IUDs are effective as a method of
contraception in women taking AEDs.
3. There is limited evidence that progesterone implants
(specifically levonorgestrel) are ineffective
in women taking enzyme-inducing AEDs.
4. Progesterone pill should be avoided.
5. There is no evidence on the effectiveness of emergency
contraception in women taking enzymeinducing AEDs.
6. There needs to be a National Pregnancy registry.

• Both the disease and its treatment may alter the
menstrual cycle and fertility.
• There are problems with drug interactions, particularly
with hormonal contraceptives.
Some methods of
hormonal contraception may not be as effective in women
taking AEDS. The effectiveness will depend on which
AED(s) are being taken. Effective contraception has an
additional importance in women with epilepsy because of
the risks associated with an unplanned pregnancy to the
women and the developing fetus.
• AEDs are associated with teratogenic effects.
• Both AEDs and uncontrolled seizures can cause
adverse effects during pregnancy.
Conversely, pregnancy and menses can affect seizure
control due to hormonally induced alteration of the seizure
threshold.
• Every pregnancy is different.

PREGNANCY
7. AED’s should be continued in pregnancy. There is no
benefit of stopping AED’s after 3-4 weeks of conception
(nural tube formed), and risk of seizures outweighs risk of
continued AED exposure in vitro.
Table 12: AED’s and Pregnancy Risk:

Management of Epilepsy in Women can be divided into 5
phases:
1. COUNSELLING
2. CONTRACEPTION
3. PREGNANCY
4. LABOUR
5. POST PARTUM AND LACTATION
COUNSELLING
• In order to enable informed decisions and choice, and
to reduce misunderstandings, women and girls with
epilepsy and their partners, as appropriate, must be given
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POST-CONCEPTION
14. Counselling about safety during child rearing, like to
keep baby in a crib next to the bed, care to avoid dropping
the baby especially JME.
15. Breast Feeding guide: All mothers should be
encouraged to breast feed.
16. The doseage of AEDs such as LTG, LEV, OXC may have
to be reduced if they were raised during pregnancy but
after 6 weeks post partum
17. Spacing
between
pregnancies
should
be
recommended and safe/ effective contraceptive methods
should be offered to all WWE.

8. When should screening for structural fetal anomalies
be performed in pregnant women
with epilepsy?
A recent NICE guideline reviewed the evidence on the
detection of structural fetal abnormalities in healthy
pregnant women.
It is recommended that ‘pregnant women should be
offered an ultrasound scan to screen for structural
anomalies, ideally between 18 to 20 weeks of gestation,
by an appropriately trained sonographer and with
equipment of an appropriate standard.
9. When should folic acid be started?
• All women nd girls on AEDs should be offered 5mg
per day of folic acid before any possibility of pregnancy.
• There is limited evidence to show that folic acid
supplementation reduces the risk of
• Neural tube defects and other congenital
malformations in women taking AEDs.
• Women who are planning pregnancy should be
advised to take 400mcg of folic acid from when they
begin trying to conceive until the 12th week of pregnancy
and that those who suspect they are pregnant and who
have not been taking supplements should start folic acid
supplements 5mg immediately and continue until the
12th week of pregnancy.
10. Serum levels of AEDs are of help during pregnancy.
The dose of AEDs should not be increased routinely if
levels are low except if seizures start occurring, and at the
time of delivery to avoid breakthrough seizures during the
stress of labour.
11. If preterm labor is threatened in women taking
enzyme-inducing AEDs, 48mg betamethasone (double
the normal dose) should be given over 48 hours.
12. Vitamin K 10mg i.m. at 34 and 36 weeks is
recommended for all women unless there is a
contraindication.
13. Some counseling points:
What are the dangers of seizures in women who are
pregnant or post-natal?
• Women and girls with epilepsy need accurate
information during pregnancy, and the possibility of status
epilepticus and SUDEP should be discussed with all
women and girls who plan to stop AED therapy
• Women and girls with generalised tonicclonic seizures
should be informed that the fetus may be at relatively
higher risk of harm during a seizure, although the absolute
risk remains very low, and the level of risk may depend on
seizure frequency.
• There is no evidence that simple focal, complex focal,
absence and myoclonic seizures adversely affect the
pregnancy or developing fetus.
• Generalized tonicclonic seizures are likely to result in
more profound hypoxia than in the nongravid state due to
increased maternal oxygen requirements. This may have
adverse affects for the fetus
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MANAGEMENT OF STATUS EPILEPTICUS Guidelines
for Pakistan:
When a convulsive seizure continues for a prolonged
period (longer than 5 minutes), or when convulsive
seizures occur one after the other with no recovery in
between patient is considered to be in Status Epilepticus.
Convulsive status epilepticus is an emergency and
requires immediate medical attention. TREAT HARD and
TREAT FAST
APPENDIX : STATUS EPILEPTICUS PROTOCOL
Definition:
1. Convulsive Status Epilepticus (CSE): in adults and
children older than 5 years is characterized by continuous
convulsive seizures lasting more than 5 minutes or two or
more seizures in 20 minutes without gaining
consciousness in between.
2. Non-convulsive status epilepticus (NCSE) is mental
status changes from baseline for at least 30 minutes
associated with ictal discharges on EEG. It should be
suspected in patient after convulsive seizure who is not
regaining consciousness.
3. Refractory Status Epilepticus: (RSE) Seizure activity
that continues after first and second line AED therapy
have failed. This can be CSE and NCSE.
MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS:
PRE-HOSPITAL STAGE: FIRST 5-10 MINUTES
• Children: Rectal diazepam 0.5mg /kg or buccal
midazolam 0.2-0.3mg/kg ; adults: rectal diazepam 10mg
or buccal midazolam 10mg (home)
• Maintain iv line as soon as possible and administer
5-10mg diazepam or 3-5 mg midazolam iv push followed
by saline flush. (EMS)
• Secure airway, breathing and circulation
HOSPITAL STAGE: 5-20 MINUTES
• Diazepam 0.2mg /kg (maximum 10mg) over
1minute,OR midazolam 0.2mg/kg ivp or im, upto 10mg;
wait 5 minutes for seizures to terminate. Order and
prepare IV phenytoin. If seizure terminates investigate
cause of seizures further, if not repeat again .in children
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<2years give neurobioniv to replace thiamine and biotin.
• Give Oxygen, stabilize airway, respitation and
hemdynamic parameters, apply pulse oxymetry.
• Send RBS, LFT, renal functions, electrolytes, BUN, and
CT scan. LP and CSF analysis if CNS infection suspected.
• Start PHT infusion 15-20mg/kg at maximum rate of
50mg/min (1mg/kg/min in small children) AVOID dilution in
glucose solution. Monitor heart rate and blood pressure,
contraindicated in patients with heart block or hypotention
SBP<95. (phosphenytoin 15-18mg PE/kg/min at max rate
of 150mg PE/min is internationally the drug of choice but
unfortunately not available in Pakistan)

• Continue coma phase for 12 hours after last seizure
• Weaning phase: reduce infusion of anaesthetic agent
every 3 hours with EEG monitoring, if seizures recur
re-institute coma with the same anaesthetic to the dose
where seizures were responsive.
• Add topiramate 200 mg bolus and 100 mg tid.
• Identify and treat medical complications correct
acidosis if pH 7.2 or if symptomatic in the form of cardiac
disturbances. Vigorously treat infections, avoid penicillin
and quinolone group of antibiotics.
• If seizures continue and autoimmune or idiosyncratic
modulation is suspected consider puse steroids and ivIG.
POST STATUS PHASE
• Maintenance therapy, all AEDs that were used to
treat the status should be continued on maintainance
dosage till patient remains seizure free for at least 3-7
days if patient awake, if GCS remains low gradually
remove under EEG coverage.

HOSPITAL STAGE : ESTABLISHED GSCE 20-60minutes:
• If seizures continue 5-10 mins after PHT, reload
5-10mg/kg iv at same rates as above
• Seizures
continue
give
Sodium
Valproate
25-35mg/kg at a rate of 6mg/kg/hr
• Arrange for intubation, anaesthesia on board
• Seizures continue give iv levitiracetam loading
1000-3000mg (adults) at 2-5mg/kg/min
• Seizures continue next stage RCE.
• Start phenobarbitone50-100mg/min IV loading dose,
and if intubated can start infusion 0.5-5mg/kg/hr or skip
to next stage RCE

TIME IN
MINUTES

1. History esp. of antiepileptic medications, drugs and
INITIAL
alcohol
ASSESSMENT 2. Airway, Breathing, Circulation with frequent vital signs
3. Obtain 2 IV access / Oxygen
4. ECG Monitoring
5. Draw blood for:
CBC, sodium, glucose, magnesium, calcium, phosphate,
LFTS, Antiepileptic drug

HOSPITAL STAGE: Refractory Status Epilepticus
(more than 60 mins)
• Prepare to intubate and transfer to ICU
• Start lacosamide 200-400mg IV 200 mg over 15
mins (adults only)
• Ideally obtain central venous access and contiuous
hemodynamic monitoring through arterial line and EEG
monitoring
• Anaesthetic agents: Adults and children midazolam
0.2mg/kg IV bolus followed by 0.1-0.4mg/kg/hour
continuous iv infusion OR propofol 2-5mg/kg IV bolus
followed by 5-10mg/kg/hr iv infusion OR thiopental
10-20mg/kg IV bolus followed by 0.5-1mg/kg/hr IV infusion
till EEG shows burst suppression (pharmacologic coma)

0-5

Drug

Initial dose

Continuous infusion dosing
recommendations-titrated to EEG
0.05-2 mg/kg/hr/CI
Breakthrough SE: 0.1-0.2 mg/kg
bolus, increase CI rate by 0.05-0.1
mg/kg/hr every 3-4 h

Serious adverse
effects
Respiratory depression
Hypotension

5-15 mg/kg, may
give additional 5-10
mg/kg; administer
at an infusion rate ≤
50 mg/min

0.5-5 mg/kg/h CI
Breakthrough SE: 5 mg/kg bolus,
increase CI rate by 0.5-1 mg/kg/h
every 12 h

Start at 20
mcg/kg/min, with
1-2 mg/kg loading
dose

30-200 mcg/kg/min CI
Use caution when administering high
doses (>80 mcg/kg/min) for extended
periods of time (i.e., >48 h)
Peds: Use caution with doses >65
msg/kg/min; contraindicated in
young children
Breakthrough SE: Increase CI rate by
5-10 mcg/kg/min every
5 min or 1 mg/kg bolus plus CI
titration
0.5-5 mg/kg/h CI
Breakthrough SE: 1-2 mg/kg bolus,
increase CI rate by 0.5-1 mg/kg/h
every 12 h

Hypotension
Respiratory depression
Cardiac depression
Paralytic ilius
At high doses,
complete loss of
neurological function
Hypotension
(especially with
loading dose in
critically ill patients)
Respiratory depression
Cardiac failure
Rhabdomyolysis
Metabolic acidosis
Renal failure (PRIS)

0.2 mg/kg;
administer at an
infusion rate of 2
mg/min

Phenytoin 15 mg/Kg IV at 50 mg/min with Blood
Pressure and ECG Monitoring --- IF SEIZURES PERSIST
If no seizures and patient not waking up EEG, if
electrographic seizures continue as GCSE

10-20

IV Valproate-30 mg/Kg OVER 10 minutes. Then give
20 mg/Kg over 5 minutes --If patient on multiple medications or hepatic failure, give
I.V Levitiracetam 1gm. over 15 minutes. IF SEIZURES
PERSIST – Call Neurology/Epilepsy Service
INTUBATE
If no clinical seizures but patient remains
unconscious EEG if Electrographic seizures
continuous EEG monitoring and INTUBATE
If PT. DNR or delay in intubation, give IV lacosamide 300
mg over 15 minutes.

Pentobarbital

Propofol

Thiopental

2-7 mg/kg,
administer at an
infusion rate ≤50
mg/min

Hypotension
Respiratory depression
Cardiac depression

Considerations
Tachyphylaxis occurs after
prolonged use
Active metabolite, renally
eliminated, rapid redistribution
(short duration), does NOT
contain propylene glycol
Requires mechanical ventilation
IV contains propylene glycol

30-60

Requires mechanical ventilation
Must adjust daily caloric intake
(1.1 kcal/ml)

> 60 min
Requires mechanical ventilation
Metabolized by pentobarbital
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Thiamine 100mg iv 50ml of 50%dextrose,along with
Midazolem 5mg IV over 1 minute.
Diazepam 5mg IV over 2 minutes and repeat in
5 minutes

6-10

Table: RSE dosing recommendations

Midazolam

STEPS

IV Phenobarbital 20 mg/Kg at 50-100 mg/min.
IV lacosamide 300mg.
Continuous EEG monitoring
IF SEIZURES PERSIST
1. Continuous IV Midazolam load 0.2 mg/Kg; repeat 0.2
to 0.4 mg/Kg bolus every 5 min until seizures stop up to
max of 2 mg/kg.
Initial cIV rate 0.1 mg/kg/h (0.05-2mg/kg/hr) OR
2. cIV Propofol Load 1 mg/Kg. Repeat 1-2 mg/kg boluses
every 3-5 min max of 10mg/kg.
Initial cIV rate is 2 mg kg/h (range 1-15 mg/kg/h)
IF SEIZURES PERSIST
1. c IVPentobarbital Load 5-10 mg/kg up to 50mg/min.
2. Repeat 5 mg/kg boluses until seizures stop.
Initial cIV rate is 1 mg/kg/h (range 0.5-10mg/kg/h) till
suppression-burst pattern on EEG monitoring
3. cIVcontinuous intravenous infusion
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ALGORITHM FOR MANAGEMENT OF GCSE
Repeat seizure
without awakening or

First Seizure
(in hospital)

Overt seizure lasting
> 7 minutes

ABC

Status
Epilepticus
protocol

Vitals
Directed Neuro
exam
Metabolic or toxic abnormality

Speciﬁc management

Sub-therapeutic
AED levels Review drug interactions
New or exam
abnormality and / or newonset unprovoked seizure

MRI / CT

Suspected CNS

infection

Lumbar puncture unless
contraindicated

Treatment of underlying
condition if any

- Consider AED for new-onset

No electrographic

seizure (see footnote for
dosages)

seizure

- Dose-adjusted AED for
seizure with sub-therapeutic
levels

EEG if seizure diagnosis
unclear or patient not
regained consciousness
after 2 hours

Ongoing
electrographic
seizure

Phenytoin loading dose 15-20 mg/kg IV over 20 min in normal saline (precipitates in D5W), administered
with HR and BP monitoring. Maintenance: 300 mg/day in adults, as a single dose or in up to 3 divided
doses; titrate to keep serum level 5-20 mg/dL. Phenytoin can also be orally loaded as 1,000 mg po stat
followed by maintenance as above.

Sodium Valproate may be loaded with 400-800 mg (max 10 mg/kg) as slow IV bolus over 3 -5
minutes followed by a continuous or intermittent infusion up to a maximum daily dose of 2.5 g. Oral
therapy and maintenance 1-2 g daily po in two or three divided doses; titrate to keep serum level 50150 mg/dL.
Levitiracetam – May be loaded 1gm in 200 ml over 15-20 minutes the maintenance of 500mg twice
daily
Lacosamide-May be loaded 300 mg IV over 10-15 minutes and maintenance at 200 mg bid.
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